Navigation Links
Keppra XR(TM) Extended-Release Tablets Filed with the FDA
Date:1/16/2008

U.S. Food and Drug Administration (FDA) has accepted for filing the New Drug Application (NDA) for the use of Keppra XR(TM) (levetiracetam) in the adjunctive treatment of partial onset seizures in adults with epilepsy

ATLANTA, Jan. 16 /PRNewswire/ -- UCB announced today that the New Drug Application (NDA) for the use of Keppra XR(TM) (levetiracetam) extended- release tablets in the adjunctive treatment of partial onset seizures in adults with epilepsy has been accepted for filing by the U.S. Food and Drug Administration (FDA).

"This filing is another important step in the development of UCB's epilepsy franchise and demonstrates our commitment to bringing new and innovative therapies to the epilepsy community," said Iris Loew-Friedrich, MD, PhD, Global Head of Development, UCB Group. "There is an ongoing need for new antiepileptic drug options without the limitations of twice daily dosing. Epilepsy therapies with more convenient dosing schedules may help encourage greater patient compliance, which is important to effective seizure control."

The filing for Keppra XR(TM) is supported by a Phase III, multicenter, randomized, double-blind, placebo-controlled study evaluating the efficacy, safety, and tolerability of extended-release levetiracetam tablets (2x500 mg) once-daily as adjunctive therapy in 158 refractory epilepsy patients, 12 to 70 years of age, with partial onset seizures.

The study met its primary endpoint for seizure reduction over placebo during the treatment period (p=0.038). The median percent reduction of partial onset seizures in the extended-release levetiracetam group was 46.1% compared to 33.4% with placebo during the 12 week treatment period. Additionally, 24.0% of patients randomized to the extended-release levetiracetam group had seizure frequency per week reduced by 75-100%, compared with 11.4% of patients in the placebo group. In the extended-release levetiracetam group 10.1% of patients had 100% reduction i
'/>"/>

SOURCE UCB
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. UCB Announces Positive Phase III Trial Results for Keppra XR(TM) (levetiracetam) Extended-Release Tablets
2. SEROQUEL XR(TM) Receives Approval From FDA for Maintenance Treatment of Schizophrenia
3. AstraZeneca Submits sNDAs for SEROQUEL XR(TM) for the Treatment of Bipolar Mania and Bipolar Depression
4. New Data Show Improvements in Work Performance in Patients with Chronic Insomnia Treated with AMBIEN CR(R) (zolpidem tartrate extended-release) Tablets CIV
5. Ranbaxy Receives Approval to Manufacture and Market Hydrocodone Bitartrate and Acetaminophen Tablets USP
6. A Phase II, Randomized, Double Blind, Placebo-Controlled Dose-Escalating Study, Meets the Clinical Endpoints of MTR106 Tablets During the Treatment of Acute Migraine Attacks Without Aura in Females
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... 31, 2015 Today, the National Association ... ) issued a report urging greater accountability by ... taken against websites illegally selling medications online. As ... Identification Program Progress Report for State and Federal ... of websites illegally distribute medications and avoid retribution. ...
(Date:7/31/2015)... 2015 According to a new market ... Dry Heat, Ethylene Oxide, Filtration, E-beam, Gamma), Services (Onsite & ... - Global Forecast to 2020", published by MarketsandMarkets, The Sterilization ... by 2020, at a CAGR of 7.6%.from 2015 to 2020. ... data T ables and 37 ...
(Date:7/31/2015)... 31, 2015  Semler Scientific, Inc. (Nasdaq: SMLR ... to healthcare insurers and physician groups, today reported financial ... "In the second quarter of 2015, ... growth of 54%, quarter over quarter revenue growth of ... base of FloChec® units of 18%," said Doug Murphy-Chutorian, ...
Breaking Medicine Technology:NABP Stresses Need for Accountability in Enforcing Internet Policies to Protect the Public From Illegal Online Drug Sellers 2NABP Stresses Need for Accountability in Enforcing Internet Policies to Protect the Public From Illegal Online Drug Sellers 3Sterilization Equipment Market is Expected to Reach USD 6.1 Billion by 2020 2Sterilization Equipment Market is Expected to Reach USD 6.1 Billion by 2020 3Sterilization Equipment Market is Expected to Reach USD 6.1 Billion by 2020 4Semler Reports Second Quarter 2015 Financial Results 2Semler Reports Second Quarter 2015 Financial Results 3Semler Reports Second Quarter 2015 Financial Results 4Semler Reports Second Quarter 2015 Financial Results 5Semler Reports Second Quarter 2015 Financial Results 6
... 7, 2011 Boston Scientific Corporation (NYSE: BSX ... the Federal Circuit affirmed the decision of the U.S. District ... in a suit involving Johnson & Johnson to be invalid. ... Johnson alleged that Boston Scientific,s PROMUS® Everolimus-Eluting Coronary Stent System ...
... Healthpoint Biotherapeutics today announced that Travis E. Baugh, ... Executive Vice President, Strategic and Commercial Development, will ... products and its R&D pipeline at two upcoming ... 2:30 pm(EDT) on Thursday, June 9, 2011 during ...
Cached Medicine Technology:Boston Scientific Announces Favorable Appellate Court Ruling Affirming Invalidity of J&J Patents 2Boston Scientific Announces Favorable Appellate Court Ruling Affirming Invalidity of J&J Patents 3Healthpoint Biotherapeutics to Present at Upcoming Investment Conferences 2
(Date:8/1/2015)... ... 01, 2015 , ... On Tuesday, July 28th, Symantec released a security industry ... been behind the attack on Anthem Inc. which resulted in one of the largest ... attacks and spear phishing campaigns. , For Joe Caruso, founder and CEO/CTO ...
(Date:8/1/2015)... , ... August 01, 2015 , ... “ reTXT ” ... at the latest and coolest applications on the market for iOS, Android, and Windows. ... shared with viewers allows users to clarify, edit and delete any message including ones ...
(Date:7/31/2015)... (PRWEB) , ... July 31, 2015 , ... Ticket Down is a reputable source of ... the MGM Grand Garden Arena. Fans of every genre of music will have an ... 18th, the first day of the festival, the following artists will perform: Sam Smith, ...
(Date:7/31/2015)... ... ... Super Bowl 50 will emanate from Levi’s Stadium in Santa Clara, CA on Sunday, ... Bowl. In the two weeks that separate the conference championships and the Super Bowl, there ... game will mark the 50th time it has been held and the festivities will take ...
(Date:7/31/2015)... (PRWEB) , ... July 31, 2015 , ... ... new industry players to know in predictive health analytics , Jvion continues ... technologies. The firm creates predictive software that targets patient and population level illness ...
Breaking Medicine News(10 mins):Health News:Frenemy at the Gates - Hackers Excel at Leveraging Trust 2Health News:Frenemy at the Gates - Hackers Excel at Leveraging Trust 3Health News:Frenemy at the Gates - Hackers Excel at Leveraging Trust 4Health News:Correct Auto-Correct and Clarify the Unclear with reTXT Messaging App 2Health News:Cheap 2015 iHeartRadio Music Festival Tickets in Las Vegas at MGM Grand Garden Arena: Ticket Down Slashes Ticket Prices on the iHeart Radio Music Festival in Vegas 2Health News:Cheap 2015 iHeartRadio Music Festival Tickets in Las Vegas at MGM Grand Garden Arena: Ticket Down Slashes Ticket Prices on the iHeart Radio Music Festival in Vegas 3Health News:Cheap 2016 Super Bowl Tickets at Levi's Stadium: Ticket Down Slashes Ticket Prices on Super Bowl 50 Tickets in Santa Clara, CA at Levi's Stadium 2Health News:Jvion Showcased as Leader in the Predictive Analytic Market 2
... United Kingdom: Many of the probotic health drinks are ... labels, say a team of microbiologists//. While established brands ... are advertised and marketed through the online medium seem ... do not contain the requisite amount of beneficial bacteria ...
... millions of people who suffer from chronic allergies to ... to develop Parkinson’s disease later in life. ... has shown that people who suffer from allergic rhinitis, ... a ‘permanent cold’, are probably at a greater risk ...
... ministry views the contamination of soft drinks with utmost seriousness//. ... note of the studies carried out by Centre for Science ... print and electronic media on Aug 2. The report of ... ,The ministry views "the contamination of soft drinks with utmost ...
... Researchers have determined the structure of DNA-modifying enzyme that ... a study published in the August 4 issue of ... School of Medicine have presented their findings on the ... DNA. The findings could help in developing antiviral ...
... The tests only report the presence of drugs and not the ... the drug mean it will affect their performance? // Probably not," ... ,"With cannabis, for instance, detection could mean the impairment ... fat cells for a month) and really has no effect on ...
... St. Louis have found that a high percentage of ... in contrast to claims that children are being overmedicated. ... are suffering from the disease and would benefit from ... found was somewhat surprising," says Richard D. Todd, M.D., ...
Cached Medicine News:Health News:Researchers Hint At The Probability Of A Link Between Rhinitis And Parkinson’ 2Health News:Researchers Hint At The Probability Of A Link Between Rhinitis And Parkinson’ 3Health News:Structure of DNA-modifying enzyme In Small Pox Determined 2Health News:Structure of DNA-modifying enzyme In Small Pox Determined 3Health News:Treatment For ADHD In Kids Inadequate 2Health News:Treatment For ADHD In Kids Inadequate 3
... The A5500 is an extremely accurate ... high frequency, low noise probe and fast ... application of the probe along the visual ... display, large 7 CRT monitor, built-in thermal ...
... most advanced IOL workstation. Accurate, efficient and ... be used with a variety of regressive, ... to the needs of the patient. Convenient ... a foot pedal for hands-free operation, audible ...
... unit with graphic display and IOL power ... units include firmware module with SRK II, ... All model DGH 5000e and DGH 5100e ... reducing the possibility of short readings. The ...
The UD-1000 incorporates the latest ultrasound technology for eyecare specialists. It is the ideal choice for your modern diagnostic laboratory. The UD-1000 combines a powerful B-sector scan system w...
Medicine Products: